Linda Tharby - Mar 17, 2025 Form 4 Insider Report for KORU Medical Systems, Inc. (KRMD)

Role
Chief Executive Officer, Director
Signature
/s/ Linda Tharby
Stock symbol
KRMD
Transactions as of
Mar 17, 2025
Transactions value $
-$109,918
Form type
4
Date filed
3/21/2025, 04:35 PM
Previous filing
Sep 30, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRMD Common Stock Options Exercise $0 +16K +1.49% $0.00 1.09M Mar 17, 2025 Direct F1, F4
transaction KRMD Common Stock Tax liability -$25.5K -8.85K -0.82% $2.89 1.08M Mar 17, 2025 Direct F2, F4
transaction KRMD Common Stock Tax liability -$84.4K -29.8K -2.77% $2.83 1.05M Mar 19, 2025 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRMD Restricted Stock Unit Options Exercise -16K -25% 47.9K Mar 17, 2025 Common Stock 16K Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents common stock issued upon vesting of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock upon vesting.
F2 Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units.
F3 Represents shares withheld to satisfy tax obligations upon vesting of previously issued restricted stock.
F4 Includes 200,000 in restricted stock awards that vest based on a schedule of the Company's market capitalization prior to 3/15/27; and 600,000 in restricted stock awards that vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25.
F5 This restricted stock unit award was granted under the Issuer's 2024 Omnibus Equity Incentive Plan. The units comprising the award vest in equal increments on March 15, 2025 and each first, second and third anniversaries thereof (each, a vesting date). Shares were withheld to satisfy applicable tax withholding obligations.

Remarks:

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person.